Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryu Watanabe

Showing results (61-70 of 158) with videos related to

Pageof 16
Sort By:
Journal of Neuroinflammation|October 22, 2013
A novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathyTsuyoshi Shirai, Hiroshi Fujii, Masao Ono, et al.
Modern Rheumatology|May 27, 2015
Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factorsMariko Ishizuka, Ryu Watanabe, Tomonori Ishii, et al.
International Journal of Molecular Sciences|March 29, 2023
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 UpdateQuang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2014
Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosusRyu Watanabe, Hiroshi Fujii, Tsuyoshi Shirai, et al.
Arthritis Research & Therapy|July 4, 2012
A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosusTsuyoshi Shirai, Hiroshi Fujii, Masao Ono, et al.
Modern Rheumatology|February 21, 2015
Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositisRyu Watanabe, Tomonori Ishii, Kyoko Araki, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2015
Synovitis in a Patient with IgG4-related DiseaseFumiko Tomiyama, Ryu Watanabe, Hiroshi Fujii, et al.
Journal of Clinical Medicine|March 17, 2025
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid ArthritisTasuku Togashi, Ryuhei Ishihara, Ryu Watanabe, et al.
Modern Rheumatology Case Reports|February 12, 2024
Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritisKazuo Fukumoto, Ryu Watanabe, Minako Tsutsumi, et al.
Lupus|March 28, 2026
Relationship between sarcopenia and lifestyle in patients with systemic lupus erythematosus: A one-institution cross-sectional analysisQi-Yun Dai, Yoshinari Matsumoto, Chisato Kawakami, et al.
Pageof 16

Showing results (61-70 of 158) with videos related to

Sort By:
Pageof 16
Journal of Neuroinflammation|October 22, 2013
A novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathyTsuyoshi Shirai, Hiroshi Fujii, Masao Ono, et al.
Modern Rheumatology|May 27, 2015
Long-term follow-up of 124 patients with polymyositis and dermatomyositis: Statistical analysis of prognostic factorsMariko Ishizuka, Ryu Watanabe, Tomonori Ishii, et al.
International Journal of Molecular Sciences|March 29, 2023
Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors-A 2023 UpdateQuang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.
Internal Medicine (Tokyo, Japan)|March 18, 2014
Successful use of intensive immunosuppressive therapy for treating simultaneously occurring cerebral lesions and pulmonary arterial hypertension in a patient with systemic lupus erythematosusRyu Watanabe, Hiroshi Fujii, Tsuyoshi Shirai, et al.
Arthritis Research & Therapy|July 4, 2012
A novel autoantibody against fibronectin leucine-rich transmembrane protein 2 expressed on the endothelial cell surface identified by retroviral vector system in systemic lupus erythematosusTsuyoshi Shirai, Hiroshi Fujii, Masao Ono, et al.
Modern Rheumatology|February 21, 2015
Successful multi-target therapy using corticosteroid, tacrolimus, cyclophosphamide, and rituximab for rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositisRyu Watanabe, Tomonori Ishii, Kyoko Araki, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2015
Synovitis in a Patient with IgG4-related DiseaseFumiko Tomiyama, Ryu Watanabe, Hiroshi Fujii, et al.
Journal of Clinical Medicine|March 17, 2025
Rheumatoid Factor: Diagnostic and Prognostic Performance and Therapeutic Implications in Rheumatoid ArthritisTasuku Togashi, Ryuhei Ishihara, Ryu Watanabe, et al.
Modern Rheumatology Case Reports|February 12, 2024
Lymphoproliferative disorder progressing after partial remission following immunosuppressive drugs withdrawal in a patient with rheumatoid arthritisKazuo Fukumoto, Ryu Watanabe, Minako Tsutsumi, et al.
Lupus|March 28, 2026
Relationship between sarcopenia and lifestyle in patients with systemic lupus erythematosus: A one-institution cross-sectional analysisQi-Yun Dai, Yoshinari Matsumoto, Chisato Kawakami, et al.
Pageof 16